Vivanza Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.11",
    "chg": -0.04,
    "chgp": "-1.86%",
    "dir": -1,
    "prev_price": "2.15",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE984E01035",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "53.73 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivanzaBioscien_only_sellers_3744396.png",
        "date": "2025-12-03 14:20:20",
        "description": "Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3734253",
        "imagepath": "",
        "date": "2025-11-28 00:24:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Trend Reversal</strong></p>\n<p>Vivanza Biosciences’ share price fell by ₹0.12 on 27 November, marking a reversal after four consecutive days of gains. This decline contrasts with the stock’s positive momentum over the past week and month, where it recorded returns of +6.54% and +13.43% respectively. These figures significantly outpace the Sensex’s modest gains of +0.10% over one week and +1.11% over one month, highlighting the stock’s recent relative strength within the market.</p>\n<p>However, despite this short-term outperformance, the stock remains deeply under pressure over longer time horizons. Year-to-date, Vivanza Biosciences has declined by 34.48%, while the Sensex has advanced by 9.70%. Over one year, the stock’s loss widens to 40.63%, compared to the Sensex..."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3733661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3733661.png",
        "date": "2025-11-27 12:25:26",
        "description": "Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amidst-unprecedented-buying-interest-3725378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3725378.png",
        "date": "2025-11-24 11:35:27",
        "description": "Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-hits-upper-circuit-amid-unprecedented-buying-interest-3720588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_buyers_3720588.png",
        "date": "2025-11-21 10:35:30",
        "description": "Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3718442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3718442.png",
        "date": "2025-11-20 15:25:30",
        "description": "Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment."
      },
      {
        "title": "Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-extreme-selling-pressure-amid-lower-circuit-trigger-3715110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3715110.png",
        "date": "2025-11-19 10:30:47",
        "description": "Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Vivanza Biosci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vivanza-biosci-fallingrising-3713008",
        "imagepath": "",
        "date": "2025-11-18 22:29:26",
        "description": "As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest.\n\nBroader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th..."
      },
      {
        "title": "Vivanza Biosciences Faces Selling Pressure with 4.84% Decline, Total Loss of 9.58% in Two Days",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-faces-selling-pressure-with-484-decline-total-loss-of-958-in-two-days-3711659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VivanzaBioscien_only_sellers_3711659.png",
        "date": "2025-11-18 11:30:42",
        "description": "Vivanza Biosciences Ltd is experiencing significant selling pressure, with a notable decline over the past two days. Despite recent short-term gains, the stock's long-term performance is troubling, showing substantial losses over the past year and three years, contrasting sharply with the Sensex's gains during the same periods."
      }
    ],
    "total": 155,
    "sid": "515837",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Jan-2026",
      "details": "We hereby enclose the Confirmation Certificate Under regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 received from Purva Sharegistry (I) Private Limited Registrar and Share Transfer Agent (RTA) of the Company for the Quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "This is to inform that pursuant to the SEBI (PIT) Reg 2015 read with the relevant circulars issued by BSE Limited and Companys Code of Conduct for prevention of Insider trading of the company the trading window for dealing in shares of the company for all designated persons and their immediate relatives shall remain closed from 01st January 2026 till 48 hours after the decleration of financial results for the Quarter ended 31st December 2025. The Date of the Board meeting for consideration of the financial results of the company for the quarter ended 31st December 2025 shall be intimated in due course.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association",
      "datetime": "18-Dec-2025",
      "details": "Pursuant to Regulation 30(2) of SEBI LODR Regulations 2015 and SEBI Circular Dated November 11 2024 the members have approved by Special Resolution through Postal Ballot the alteration of Main Object Clause of MOA by inserting a New Sub-Clause 7 after existing Sub-clause 6 of Clause III(A). Details are provided in Annexure A. The amendment is subject to the necessary regulatory approvals.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 14:20:20

Vivanza Biosciences Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an order book dominated exclusively by sell orders. This extreme market behaviour signals distress selling and a lack of buyer interest, reflecting a challenging phase for the pharmaceutical and biotechnology company.

Why is Vivanza Biosci. falling/rising?

2025-11-28 00:24:32

Recent Price Movement and Trend Reversal Vivanza Biosciences’ share price fell by ₹0.12 on 27 November, marking a reversal after four consecutive days of gains. This decline contrasts with the stock’s positive momentum over the past week and month, where it recorded returns of +6.54% and +13.43% respectively. These figures significantly outpace the Sensex’s modest gains of +0.10% over one week and +1.11% over one month, highlighting the stock’s recent relative strength within the market. However, despite this short-term outperformance, the stock remains deeply under pressure over longer time horizons. Year-to-date, Vivanza Biosciences has declined by 34.48%, while the Sensex has advanced by 9.70%. Over one year, the stock’s loss widens to 40.63%, compared to the Sensex...

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-27 12:25:26

Vivanza Biosciences Ltd is experiencing a pronounced sell-off, marked by a lower circuit scenario with exclusively sell orders dominating the queue. The stock’s performance today reflects severe distress selling, with no buyers stepping in to absorb the pressure, signalling heightened investor concern in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-24 11:35:27

Vivanza Biosciences Ltd has captured market attention with extraordinary buying momentum, registering a sharp price rise accompanied by an absence of sellers. This rare scenario suggests the stock may sustain its upper circuit status over multiple sessions, reflecting intense demand within the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Surges with Unprecedented Buying Interest Amid Upper Circuit Lock

2025-11-21 10:35:30

Vivanza Biosciences has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-20 15:25:30

Vivanza Biosciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, marked by a lower circuit scenario with only sell orders in the queue. The stock has recorded consecutive declines over the past four days, signalling distress selling and a lack of buyer interest amid a challenging market environment.

Vivanza Biosciences Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-19 10:30:47

Vivanza Biosciences Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue today. The stock has recorded a sharp decline of 4.66% in a single day, underperforming the Sensex which posted a modest gain of 0.27%. This distress selling signals heightened investor caution in the Pharmaceuticals & Biotechnology sector.

Why is Vivanza Biosci. falling/rising?

2025-11-18 22:29:26

As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest. Broader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. Th...

Vivanza Biosciences Faces Selling Pressure with 4.84% Decline, Total Loss of 9.58% in Two Days

2025-11-18 11:30:42

Vivanza Biosciences Ltd is experiencing significant selling pressure, with a notable decline over the past two days. Despite recent short-term gains, the stock's long-term performance is troubling, showing substantial losses over the past year and three years, contrasting sharply with the Sensex's gains during the same periods.

View All News

Announcement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

02-Jan-2026 | Source : BSE

We hereby enclose the Confirmation Certificate Under regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 received from Purva Sharegistry (I) Private Limited Registrar and Share Transfer Agent (RTA) of the Company for the Quarter ended 31st December 2025

Closure of Trading Window

26-Dec-2025 | Source : BSE

This is to inform that pursuant to the SEBI (PIT) Reg 2015 read with the relevant circulars issued by BSE Limited and Companys Code of Conduct for prevention of Insider trading of the company the trading window for dealing in shares of the company for all designated persons and their immediate relatives shall remain closed from 01st January 2026 till 48 hours after the decleration of financial results for the Quarter ended 31st December 2025. The Date of the Board meeting for consideration of the financial results of the company for the quarter ended 31st December 2025 shall be intimated in due course.

Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

18-Dec-2025 | Source : BSE

Pursuant to Regulation 30(2) of SEBI LODR Regulations 2015 and SEBI Circular Dated November 11 2024 the members have approved by Special Resolution through Postal Ballot the alteration of Main Object Clause of MOA by inserting a New Sub-Clause 7 after existing Sub-clause 6 of Clause III(A). Details are provided in Annexure A. The amendment is subject to the necessary regulatory approvals.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

Vivanza Biosciences Ltd has announced 1:10 stock split, ex-date: 24 Mar 23

BONUS

No Bonus history available

RIGHTS

No Rights history available

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."